Showing results (261-270 of 312) with videos related to

Sort By:
Pageof 32
La Clinica Terapeutica|May 31, 2001
[Second-line chemotherapy and new drugs for ovarian carcinoma]D Priolo, G Antonelli, S Calì, et al.
Infection|October 19, 2014
Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patientsF Falasca, P Maida, A Gaeta, et al.
The Science of the Total Environment|November 17, 2020
A physicochemical model for rationalizing SARS-CoV-2 concentration in sewage. Case study: The city of Thessaloniki in GreeceM Petala, D Dafou, M Kostoglou, et al.
Scientific Reports|August 2, 2016
HCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2M Granato, C Zompetta, E Vescarelli, et al.
Clinical and Experimental Immunology|June 1, 1996
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapyG Antonelli, G Giannelli, M Currenti, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|May 1, 1989
[Acid-labile alpha interferon produced by peripheral blood mononuclear cells stimulated by cells infected by HIV]F Dianzani, M R Capobianchi, F De Marco, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 10, 1998
Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1aG Antonelli, F Bagnato, C Pozzilli, et al.
Haematologica|July 1, 1992
In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemiaL Catani, L Gugliotta, G Zauli, et al.
AIDS Research and Human Retroviruses|October 29, 2000
Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapyA Isgrò, I Mezzaroma, A Aiuti, et al.
International Journal of Immunopharmacology|January 1, 1991
The combined treatment of human peripheral blood mononuclear cells with thymolymphotropin and interleukin 2 increases PPD-driven T-cell proliferation and IL-2 induced cellular cytotoxicity against HIV-infected cellsA M Di Massimo, M S Gilardini Montani, M S Gilardini, et al.
Pageof 32